Found 5 results
Filters: Author is Tuttle, Katherine R  [Clear All Filters]
2017
Levin A, Tonelli M, Bonventre J, Coresh J, Donner J-A, Fogo AB, Fox CS, Gansevoort RT, Heerspink HJL, Jardine M et al..  2017.  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.. Lancet. 390(10105):1888-1917.
2016
Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K et al..  2016.  Complete Remission in the Nephrotic Syndrome Study Network.. Clin J Am Soc Nephrol. 11(1):81-9.
Brosius FC, Tuttle KR, Kretzler M.  2016.  JAK inhibition in the treatment of diabetic kidney disease.. Diabetologia. 59(8):1624-7.
2015
Anderberg RJ, Meek RL, Hudkins KL, Cooney SK, Alpers CE, Leboeuf RC, Tuttle KR.  2015.  Serum amyloid A and inflammation in diabetic kidney disease and podocytes.. Lab Invest. 95(3):250-62.
2013
Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PXK, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ et al..  2013.  Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach.. Kidney Int. 83(4):749-56.